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Oxidative stress biomarkers have been observed in peripheral blood of chronic periodontitis patients; however, their associations
with periodontitis were not consistent. This meta-analysis was performed to clarify the associations between chronic periodontitis
and oxidative biomarkers in systemic circulation. Electronic searches of PubMed and Embase databases were performed until
October 2014 and articles were selected to meet inclusion criteria. Data of oxidative biomarkers levels in peripheral blood of
periodontitis patients and periodontal healthy controls were extracted to calculate standardized mean differences (SMDs) and
95% confidence intervals (CIs) by using random-effects model. Of 31 eligible articles, 16 articles with available data were included
in meta-analysis. Our results showed that periodontitis patients had significantly lower levels of total antioxidant capacity (SMD
= −2.02; 95% CI: −3.08, −0.96; 𝑃 = 0.000) and higher levels of malondialdehyde (SMD = 0.99; 95% CI: 0.12, 1.86; 𝑃 = 0.026) and
nitric oxide (SMD = 4.98; 95% CI: 2.33, 7.63; 𝑃 = 0.000) than periodontal healthy control. Superoxide dismutase levels between two
groups were not significantly different (SMD = −1.72; 95% CI: −3.50, 0.07; 𝑃 = 0.059). In conclusion, our meta-analysis showed
that chronic periodontitis is significantly associated with circulating levels of three oxidative stress biomarkers, indicating a role of
chronic periodontitis in systemic diseases.
1. Introduction
Chronic periodontitis, characterized by inflammation and
destruction of periodontal supporting tissues, is one of the
most common oral diseases worldwide. Over 47% of Amer-
ican people had chronic periodontitis [1], and the preva-
lence is even higher in developing countries [2]. Chronic
periodontitis is initially caused by various hyperresponsive
and destructive products of immune response stimulated by
microbial plaque around the gingival margin.
In the pathogenesis of periodontitis, polymorphonuclear
leukocytes (PMN) act as the primary mediators of the
host response against proliferating periodontal pathogenic
microorganisms. Activated PMN produce a large amount
of reactive oxygen species (ROS) and result in destruction
of periodontal tissues [3, 4]. There is some suggestive evi-
dence that periodontal inflammation might be associated
with systemic oxidative stress. Recently, abundant evidence
has shown that periodontal diseases were highly associated
with several inflammation-related systemic diseases, such as
chronic respiratory diseases [5], cardiovascular disease [6],
and diabetes mellitus [7]. Oxidative stress plays an important
role in the pathogenesis of these diseases [8–11]. It has been
hypothesized that oxidative stress arising from periodontal
lesions may be an important cause of systemic inflammation.
Some but not all epidemiological studies have shown that
biomarkers levels of oxidative stress in the peripheral blood
of periodontitis patients were different from periodontal
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healthy subjects [12–14]. However, different levels of oxidative
stress biomarkers had been detected in peripheral blood of
chronic periodontitis patients in different studies, and also
their findings were not consistent.
To test the hypothesis that chronic periodontitis is asso-
ciated with systemic oxidative stress, we therefore carried out
a meta-analysis of all published relevant cross-sectional, case
control, and intervention studies to provide a comprehensive
and quantitative synthesis of accumulative evidence.
2. Methods
2.1. Search Strategy. A literature search was conducted using
the PubMed and Embase databases update to October 2014.
The search strategy was as follows: (1) keywords “oxidat∗,”
“antioxidat∗,” “oxidant∗,” “antioxidant∗,” “redox,” “reactive
oxygen species,” “ROS,” and common used oxidative stress
biomarkers keywords “total antioxidant capacity,” “TAOC,”
“total oxidant status,” “TOS,” “total antioxidant status,” “TAS,”
“oxidative stress index,” “OSI,” “nitric oxide,” “malondi-
aldehyde,” “MDA,” “superoxide dismutase,” “SOD,” “reactive
oxygen metabolites,” “ROM,” “glutathione,” “GSH,” “glu-
tathione peroxidase,” “GPx,” “8-hydroxy-deoxyguanosine,”
“8-OHdG,” and “catalase” were connected by Boolean oper-
ator “OR”; (2) keywords “serum,” “plasma,” and “blood” were
connected by Boolean operator “OR”; (3) the above search
results and the keyword “periodont∗” were connected by
Boolean operator “AND”. All keywords were restricted in title
or abstract without the language limitation.
2.2. Study Selection. Two reviewers scanned the titles and
abstracts of all above searched articles independently to look
for the relevant studies reporting the biomarkers levels of
oxidative stress in periodontitis patients and healthy controls.
The inclusion criteria were as follows: (1) study subjects were
human adults; (2) 7.both periodontitis patients group and
periodontal healthy control groupwere included in the study;
(3) at least one oxidative stress biomarker was measured in
peripheral blood samples; (4) language was English. If any of
above criteria could not be identified only through title and
abstract, full text of the article was reviewed.
Full texts of all above included articles were then reviewed
for a further selection. The exclusion criteria were as follows:
(1) smokers and/or subjects with systemic diseases were
not excluded from periodontitis group and/or periodontal
healthy control group; (2) biomarkers levels were only shown
by histogram with no detailed data; (3) if two articles have
the same study population, only the latest published article
was selected; (4) oxidative biomarkers were only measured
in red blood cells or lymphocytes. Any disagreements were
discussed for a consensus.
2.3. Data Extraction. Data were extracted by two reviewers
independently. Mean ± SD, median (min–max), or median
(25%–75%) of peripheral blood oxidative stress biomarkers in
periodontitis patients and periodontal healthy control groups
was extracted. If it was a clinical intervention study, we only
extracted the baseline data before periodontal treatment.
When there were more than two groups in one study, we only
focused on the data of systemic healthy periodontitis patients
and healthy control.
2.4. Quality Assessment. Newcastle-Ottawa Quality Assess-
ment Scale (NOS) (http://www.ohri.ca/programs/clinical
epidemiology/oxford.asp) was used to assess the method-
ological quality of all the included nonrandomized studies.
The NOS for case control studies includes three domains
(selection, comparability, and outcomes) and eight items.
A study can be awarded a maximum of one star for each
numbered item within the selection and exposure categories.
Amaximumof two stars can be given for comparability. Clin-
ical intervention studies included in this study were assessed
with the same scale as case control studies, because only
baseline data were focused on and extracted in our analysis.
Two reviewersworked independently, and discrepancieswere
resolved by discussion.
2.5. Statistical Analyses. Meta-analyses were conducted to
summarize the differences levels of oxidative stress biomark-
ers between periodontitis patients and healthy controls, if
there were 3 more studies reporting the same biomarker
measurement and the biomarker levels were expressed by
mean ± SD.
Since the included studies used different assay methods
and units for the same biomarker, we calculated the standard-
ized mean difference (SMD) and 95% confidence interval
(CI) as a summary statistic inmeta-analysis for the difference
of the levels of each biomarker between periodontitis patients
and periodontal healthy controls. SMD is the mean divided
by the standard deviation of a difference in each biomarker
between patients and controls and can be seen as the mean
difference that would have been obtained if all data were
transformed to a scale where the standard deviation within
groups was equal to 1.0.
Heterogeneity among studies was assessed by 𝑄 test,
which indicated a significant heterogeneity if 𝑃 value <0.05.
We also quantified the extent of heterogeneity with the
𝐼
2 value, where the percentages of 𝐼2 25–50%, 50–75%,
and >75% indicate low, medium, and high heterogeneity,
respectively. A random-effects model was used to calculate
SMDwhen there was a significant heterogeneity; otherwise a
fixed-effects model was used. Statistical analyses were carried
out using the Stata statistical software version 12.0 (Stata,
College Station, TX, USA).
3. Results
3.1. Study Selection and Characteristics. A total of 297 and
294 articles were separately screened based on electronic
search from PubMed and Embase database. 329 articles
were left after duplicates were removed. Only 31 relevant
articles published from December 2002 to September 2014,
including 21 cross-sectional or case-control design studies
and 10 clinical intervention studies, were finally selected after
a title or abstract review and a full text review according to
the exclusion and inclusion criteria. At last, 16 articles were
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Articles after duplicates removed
Articles searched from PubMed
Potentially relevant articles
Irrelevant articles excluded based on titles and abstracts 
Inclusion criteria:
1. study subjects were human adults;
2. both periodontitis patients group and periodontal healthy
control group were included in the study
3. at least one oxidative stress biomarker was measured in 
peripheral blood.
4. language was English.
Reasons of exclusion:
Articles searched from Embase
Articles were finally included 
Articles for meta-analysis
review (N = 276) or full text review (N = 7)
N = 297
N = 329
N = 46
N = 294
1. smokers and/or subjects with systemic diseases were not
excluded from periodontitis group and/or periodontal
healthy control group (N = 7);
2. biomarkers levels were only shown by histogram with no
detailed data (N = 5);
4. oxidative stress biomarkers were only measured in red blood
cells or lymphocytes (N = 2).
3. two articles had the same study population ( N = 1);
N = 31
N = 16
The same biomarker was measured in less than 3 studies (N = 15)
Articles excluded based on full text review (N = 15)
Figure 1: Flow chart of the process of study selection.
included in meta-analysis.The process of study selection and
the specific information of these studies were depicted in
Figure 1 and basic characteristics of all included studies were
summarized in Table 1.
3.2. Quality Assessment. The results of quality assessment
with NOS were shown in Supplemental Table 1 available
online at http://dx.doi.org/10.1155/2014/931083. All included
studies had middle or high quality. Seven studies were given
6 stars, 20 studies were given 7 stars, and 4 studies were
given 8 stars. Almost all studies met the NOS criteria for case
definition andhad good representativeness of cases.However,
for selection of controls, almost all studies derived from the
same population as the cases, but hospital controls were used.
In all studies, controls had good periodontal status when
they were included in the studies, but these studies did not
explicitly state that controls had no history of periodontitis
except 4 studies.
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Smoking and systemic diseases are the main confounders
to induce systemic oxidative stress. Because studies with
smokers and subjects that had systemic diseases in both
groups were excluded during study selection procedure, all
included studies had good comparability of cases and controls
and were given two stars.
For exposure, oxidative biomarkers levels in case and
control groups were all determined in laboratory and had
secure record. Response rate was the same for both groups.
So all included studies were given 3 stars.
3.3. Oxidative Biomarkers in the Meta-Analysis. Meta-analy-
ses of four oxidative biomarkers including total antioxidant
capacity (TAOC), malondialdehyde (MDA), superoxide dis-
mutase (SOD), and nitric oxide (NO) were performed
with random-effects model. Significant heterogeneity existed
among studies (all 𝑃 < 0.001 and 𝐼2 > 90%).The results were
presented in Figure 2.
In total, TAOC was determined in 9 studies. 7 studies
showed lower TAOC levels in periodontitis group than
in periodontal health group, and the other two showed a
nonsignificant difference between two groups. Meta-analysis
results show that periodontitis patients had lower TAOC
levels than periodontal healthy controls (SMD = −2.02; 95%
CI: −3.08, −0.96; 𝑃 = 0.000).
MDA was determined in 5 studies; 2 studies showed
higher levels in periodontitis group than in periodontal
health group, and the other three showed a nonsignificant
difference between two groups. Meta-analysis results show
that periodontitis patients had higher MDA levels than
periodontal healthy controls (SMD = 0.99; 95% CI: 0.12, 1.86;
𝑃 = 0.026).
Of 6 articles that reported SOD, 5 showed lower SOD lev-
els in periodontitis group than in periodontal health group,
and the other one showed an opposite significant difference.
The finalmeta-analysis results show nonsignificant difference
between two groups (SMD = −1.72; 95% CI: −3.50, 0.07; 𝑃 =
0.059).
All the 4 studies that determined NO showed higher
NO levels in periodontitis group than in periodontal health
group, and meta-analysis shows the same results (SMD =
4.98; 95% CI: 2.33, 7.63; 𝑃 = 0.000).
4. Discussion
This meta-analysis systematically summarized the results
of 16 independent studies from different countries and
suggested that oxidative stress biomarkers TAOC levels in
peripheral blood were lower and MDA and NO levels in
peripheral blood were higher in periodontitis patients than
healthy subjects, which indicated an elevation in systemic
oxidative stress status in periodontitis patients. However,
SOD levels in peripheral bloodwere not significantly different
between periodontitis patients and healthy subjects. Taken
together, these results clearly show that chronic periodontitis
is significantly related to some but not allmarkers of oxidative
stress status of systemic circulation.
There were no well-validated biomarkers of oxidative
stress and various biomarkers were used in different studies.
Antioxidants, enzymes, and the oxidation products of pro-
tein, lipids, and DNA were widely used to indicate the
oxidative status and also acted as oxidative stress biomarkers.
Most of biomarkers were onlymeasured in one or two studies
of the 31 included relevant articles. Ourmeta-analysis focused
on biomarkers that were measured and reported at least
in three studies, which ensure enough statistical power of
meta-analysis. Systemic diseases were associated with ROS
[9, 10, 15, 16], and cigarette can produce thousands of kinds
of ROS molecules [17], so studies with patients of systemic
disease or smokers were excluded.
Our results showed that TAOC levels decreased and
MDA and NO levels increased in the peripheral blood of
chronic periodontitis patients. MDA is the principal product
of polyunsaturated fatty acid peroxidation that can indicate
the increase of oxidative stress [18]. NO is a short-lived
reactive free radical and is synthesized by the oxidative
process of the guanidine of the amino acid L-arginine [19].
These suggested that periodontal inflammation might trig-
ger systemic oxidative stress. PMN activation in peripheral
blood could result in the increment of ROS in circulation.
Matthews et al. demonstrated that peripheral neutrophils
(a subgroup of PMN) from chronic periodontitis patients
showed an increase of extracellular ROS release in vitro
without exogenous stimulation [20]. Dias et al. found that
proinflammatory cytokines such as IL-8, GM-CSF, and IFN-
𝛼 increased in the plasma of periodontitis patients. These
cytokines in periodontitis patients were more effective in
stimulating neutrophil superoxide production than those
in healthy controls [21]. Periodontitis may cause oxidative
damage to multiple distant organs. An animal research
showed that excessive production of lipid peroxide following
periodontal inflammation was involved in oxidative DNA
damage of the brain, heart, liver, and kidney in rats [22].
SOD is an enzyme that catalyses the dismutation of O
2
∙−
(a ROS molecular) to H
2
O
2
and O
2
[23]. Although five
studies showed lower SOD levels in periodontitis group than
in periodontal health group and the other one showed an
opposite significant difference, all these studies suggested the
same conclusion that periodontitis could alter systemic SOD
levels. When SOD levels were found lower in periodontitis
patients, it can be explained as more superoxides were
induced as periodontal inflammation. More SOD would
be consumed and cause SOD level decrease. On the other
hand, when SOD levels were found higher in periodontitis
patients, it can be explained as that more SODwere produced
to afford biological protection against increased superoxide
generation during periodontal inflammation. However, our
meta-analysis result of six studies showed that SOD levels
hadno significant difference betweenperiodontitis group and
healthy subjects.
This meta-analysis provides overall evidence on the
relation between available biomarkers of oxidative stress
and chronic periodontitis from human peripheral blood
samples. However, there are some limitations caused by study
heterogeneity, such as designs, sample sizes, and methods of
biomarker measurement. There was a remarkable variability
among selected studies regarding the types of oxidative stress
biomarkers. In total, more than a dozen different biomarkers
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Biomarker First author (year) Sample
Periodontitis group Control group Meta-SMD
SMD 95% CI Weight (%)
TAOC Serum
Serum
50 50 10.95
25 25 11.16
Plasma 25 25 10.2
Whole blood 15 15 10.96
Plasma 30 30 11.47
Serum 27 25 11.42
Plasma 35 32 11.53
Serum 31 26 11.44
Plasma 10 10 10.87
248 238 100
0.54 ± 0.10
0.50 ± 0.23
1.30 ± 0.11
37.13 ± 7.14
559 ± 53.2
0.59 ± 0.20
507 ± 92
0.53 ± 0.19
501.8 ± 123
−5.51
−2.47
−5.46
−1.79
−0.90
−0.78
−0.14
−0.95
−0.68
−2.02
−6.37
−3.21
−6.69
−2.65
−1.43
−1.35
−0.62
−1.50
−1.58
−3.08
−4.64
−1.73
−4.24
−0.94
−0.37
−0.22
0.34
−0.40
0.23
−0.96Total
1.21 ± 0.14∗
1.26 ± 0.37∗
2.32 ± 0.24∗
52.40 ± 9.71∗
625 ± 88.7∗
0.75 ± 0.21∗
520 ± 100
0.72 ± 0.21∗
577.9 ± 99.8
I2 (variation in SMD attributable to heterogeneity) = 95.5%
Estimate of between-study variance 𝜏2 = 2.4771
Test of SMD = 0 : z = 3.74 P = 0.000
TAOC, total antioxidant capacity; ∗P < 0.05, periodontitis group compared with control group.
Mean ± SD Mean ± SD D + L, SMD, 95% CIn n
Heterogeneity 𝜒2 = 177.07 (d.f. = 8) P = 0.000
−6.69 6.69
Thomas (2014) [3]
Thomas (2014) [4]
Dhotre (2012) [20]
Konuganti (2012) [17]
Sulaiman (2010) [23]
Akalin (2009) [27]
Chapple (2007) [31]
Baltacioğlu (2006) [32]
Chapple (2002) [33]
MDA Serum 33 30 0.17 0.67 20.52
Plasma 30 30 1.21 1.77 20.19
Serum 25 25 3.41 4.29 17.95
Serum 48 35 0.33 0.77 20.82
Serum 36 28 0.13 0.62 20.52
172 148 0.99 1.86 100
Biomarker First author (year) Sample
Periodontitis group Control group Meta-SMD
SMD 95% CIMean ± SD Mean ± SDn n
Total
0.62 ± 0.14
17.56 ± 6.07
6.44 ± 1.06
0.72 ± 0.13
0.60 ± 0.16
0.60 ± 0.08
8.62 ± 8.46∗
3.71 ± 0.40∗
0.68 ± 0.11
0.58 ± 0.16
−0.32
0.66
2.53
−0.11
−0.37
0.12
I2 (variation in SMD attributable to heterogeneity) = 92.3%
Estimate of between-study variance 𝜏2 = 0.8962
Test of SMD = 0 : z = 2.22 P = 0.026
Heterogeneity 𝜒2 = 51.79 (d.f. = 4) P = 0.000
MDA, malondialdehyde; ∗P < 0.05, periodontitis group compared with control group.
D + L, SMD, 95% CIWeight (%)
−4.29 4.29
Baltacioğlu (2014) [7]
Trivedi (2014) [10]
Dhotre (2012) [20]
Wei (2010) [24]
Akalin (2007) [30]
SOD Serum 50 50 16.62
Serum 20 22 16.75
Serum 25 25 16.09
Serum 48 35 16.89
Serum 27 25 16.80
Serum 31 26 16.85
201 183 100
Biomarker First author (year) Sample
Periodontitis group Control group Meta-SMD
SMD 95%CI Weight (%)Mean ± SD Mean ± SD D + L, SMD, 95% CIn n
I2 (variation in SMD attributable to heterogeneity) = 97.9%
Estimate of between-study variance 𝜏2 = 4.8444
Test of SMD = 0 : z = 1.89 P = 0.059
Heterogeneity 𝜒2 = 235.14 (d.f. = 5) P = 0.000
Total
16.55 ± 3.03
60.92 ± 10.88
3.43 ± 0.23
134.3 ± 22.19
1.20 ± 0.41
1.18 ± 0.46
40.03 ± 6.68∗
70.44 ± 11.23∗
5.62 ± 0.62∗
100.4 ± 19.23∗
1.87 ± 0.67∗
1.67 ± 0.74∗
−4.53
−0.86
−4.68
1.61
−1.22
−0.81
−1.72
−5.27
−1.50
−5.77
1.11
−1.81
−1.36
−3.50
−3.78
−0.23
−3.60
2.12
−0.62
−0.27
0.07
SOD, superoxide dismutase; ∗P < 0.05, periodontitis group compared with control group.
−5.77 5.77
Thomas (2014) [3]
Chakraborty (2014) [9]
Dhotre (2012) [20]
Wei (2010) [24]
Akalin (2009) [27]
Baltacioğlu (2006) [32]
NO Serum 20 20 1.68 0.95 2.40 25.99
Serum 20 20 6.88 5.21 8.55 23.98
Serum 25 25 6.75 5.29 8.20 24.53
Serum 30 30 4.86 3.84 5.88 25.50
95 95 4.98 2.33 7.63 100
Biomarker First author (year) Sample
Periodontitis group Control group Meta-SMD
SMD 95% CI Weight (%)Mean ± SD Mean ± SD D + L, SMD, 95% CIn n
Total
9.38 ± 3.11
15.75 ± 1.97
54.8 ± 2.93
0.59 ± 0.10
5.33 ± 1.42∗
4.89 ± 1.05∗
31.80 ± 3.83∗
0.22 ± 0.04∗
I2 (variation in SMD attributable to heterogeneity) = 95.4%
Estimate of between-study variance 𝜏2 = 6.8757
Test of SMD = 0 : z = 3.69 P = 0.000
Heterogeneity 𝜒2 = 65.61 (d.f. = 3) P = 0.000
NO, nitric oxide; ∗P < 0.05, periodontitis group compared with control group.
−8.55 8.55
Wadhwa (2013) [15]
Mani Sundar (2013) [16]
Dhotre (2012) [20]
Menaka (2009) [25]
Figure 2: Meta-analysis of oxidative stress biomarkers in peripheral blood of periodontitis patients and controls.
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were detected in all these selected studies. All biomarkers
conducted in meta-analysis were only detected in four to
nine studies. Less studies numbers and small sample size
may reduce the statistical power of analysis. On the another
hand, different measurement methods were used in different
studies even for the same oxidative stress biomarker, so that
the biomarker levels were in different orders of magnitude
or have different units in different studies. Effect scale SMD
was used in this meta-analysis as its advantages could reduce
this discrepancy. Random-effectsmodel was applied for SMD
estimation of biomarkers with high heterogeneity (all 𝐼2 >
90%) among studies. The heterogeneity may also be induced
by different definition of chronic periodontitis, different
study populations (sex and age), and different biological
specimens (serum, plasma, or whole blood) among different
studies. Different study designs (cross-sectional, case control,
or interventional study) may also produce the heterogeneity.
In addition, inherent limitations of the cross-sectional and
case control study designs do not allow inferences about
causality concerning the association.
5. Conclusion
Our meta-analysis results suggested that oxidative biomark-
ers TAOC, MDA, and NO levels from peripheral blood
samples were significantly different between periodontitis
patients and healthy subjects. This evidence suggested that
chronic periodontitis was associated with systemic oxidative
stress in human bodies. Our findings further indicated that
clinical intervention of periodontitis may be beneficial for
periodontitis patients’ systemic oxidative stress control and
reduce its potential effect to systemic diseases. Prospective
studies and randomized trials are needed to verify this
hypothesis in the future.
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